DekaBank Deutsche Girozentrale’s Pliant Therapeutics PLRX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,000	Closed	-$633K	–	1293
2025 Q4	$633K	Hold	40,000	–	–	﹤0.01%	961
2025 Q3	$57K	Hold	40,000	–	–	﹤0.01%	1292
2025 Q2	$54K	Hold	40,000	–	–	﹤0.01%	1300
2025 Q1	$56K	Hold	40,000	–	–	﹤0.01%	1286
2024 Q4	$531K	Hold	40,000	–	–	﹤0.01%	994
2024 Q3	$446K	Hold	40,000	–	–	﹤0.01%	1036
2024 Q2	$422K	Hold	40,000	–	–	﹤0.01%	1036
2024 Q1	$566K	Hold	40,000	–	–	﹤0.01%	983
2023 Q4	$764K	Hold	40,000	–	–	﹤0.01%	955
2023 Q3	$648K	Hold	40,000	–	–	﹤0.01%	960
2023 Q2	$738K	Buy	40,000 +10,000	+33%	+$237K	﹤0.01%	942
2023 Q1	$782K	Buy	+30,000	New	+$854K	﹤0.01%	927
2021 Q4	–	Sell	-12,000	Closed	-$195K	–	1465
2021 Q3	$195K	Hold	12,000	–	–	﹤0.01%	1214
2021 Q2	$333K	Hold	12,000	–	–	﹤0.01%	1131
2021 Q1	$443K	Hold	12,000	–	–	﹤0.01%	1047
2020 Q4	$294K	Buy	+12,000	New	+$301K	﹤0.01%	1126

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

DekaBank Deutsche Girozentrale's PLRX Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 40,000 shares — an estimated $633K sold.

DekaBank Deutsche Girozentrale first reported a position in PLRX in Q4 2020 and held it in 16 quarters. The position peaked at $782K in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 40,000 Pliant Therapeutics shares in Q1 2026, an estimated $633K.
DekaBank Deutsche Girozentrale first reported a position in Pliant Therapeutics in Q4 2020 and held it in 16 quarters.
DekaBank Deutsche Girozentrale's Pliant Therapeutics position peaked at $782K in Q1 2023.
91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.